CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Research works printed but not linked: 3
- 47. Rousseau BA, Hou Z, Gramelspacher MJ, Zhang Y, Mol. Cell (2018), doi:10.1016/j.molcel. 2018.01.025. · doi:10.1016/j.molcel
- 63. Chen JS, Ma E, Harrington LB, Tian X, Doudna JA, bioRxiv, 226993 (2017).
- 71. Charlesworth CT et al., bioRxiv, 243345 (2018).
Cited by
Items 401–500 of 1,000
Hochrein, L. M., Li, H., & Pierce, N. A. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00037 · Cited by 37
LncRNAs in domesticated animals: from dog to livestock species
Lagarrigue, S., Lorthiois, M., Degalez, F., Gilot, D., & Derrien, T. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09928-7 · Cited by 39
“To assign functions to lncRNAs, geneticists have successfully generated knock-outs (KO) or knock-downs (KD) of lncRNAs in cells or animal models (Knott and Doudna 2018).”
BackgroundEngineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool
Li, T., Zhang, L., Lu, T., Zhu, T., Feng, C., Gao, N., Liu, F., Yu, J., Chen, K., Zhong, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202206517 · Cited by 43
Rabuma, T., Moronta-Barrios, F., & Craig, W. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1483279 · Cited by 34
Qian, C., Wu, H., Shi, Y., Wu, J. F., & Chen, H. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.127440 · Cited by 34
Matsui, K., & Yasui, Y. (2020) · Theoretical and Applied Genetics · doi:10.1007/s00122-020-03572-6 · Cited by 34
Single-Molecule Imaging of Protein Interactions and Dynamics
Luo, F., Qin, G., Xia, T., & Fang, X. (2020) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-091619-094308 · Cited by 35
“In comparison, the recently developed CRISPR/Cas9 system is highly controllable depending onWatson–Crick base pairing, and the construction of the guide (g)RNA sequence is convenient and simple, which makes it the commonly used system at present (57).”
BackgroundDynamics of Staphylococcus aureus Cas9 in DNA target Association and Dissociation
Zhang, S., Zhang, Q., Hou, X., Guo, L., Wang, F., Bi, L., Zhang, X., Li, H., Wen, F., Xi, X., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050184 · Cited by 34
“…and high efficiency of these systems have given rise to their wide in vivo applications as versatile genome tools in various organisms, such as in genome editing, transcription modulation, and live-cell imagining of chromosomal loci (Mali et al , 2013; Ma et al , 2016; Knott & Doudna, 2018).”
An optimized base editor with efficient C-to-T base editing in zebrafish
Zhao, Y., Shang, D., Ying, R., Cheng, H., & Zhou, R. (2020) · BMC Biology · doi:10.1186/s12915-020-00923-z · Cited by 33
Zuo, Z., Zolekar, A., Babu, K., Lin, V. J. T., Hayatshahi, H. S., Rajan, R., Wang, Y.-C., & Liu, J. (2019) · eLife · doi:10.7554/elife.46500 · Cited by 33
The Many Faces of Gene Regulation in Cancer: A Computational Oncogenomics Outlook
Lemus, E. H., Reyes-Gopar, H., Enríquez, J. E., & Ochoa, S. (2019) · Genes · doi:10.3390/genes10110865 · Cited by 34
Recent advances in mammalian reproductive biology
Wen, L., Liu, Q., Xu, J.-J., Liu, X., Shi, C.-Y., Yang, Z., Zhang, Y., Xu, H., Liu, J., Yang, H., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1572-7 · Cited by 35
Lu, P. Z., Wang, Q., Zou, M., Qin, Y.-D., Vasseur, L., Chu, L., Zhai, Y.-L., Dong, S., Liu, L., He, W., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01585 · Cited by 33
“RNAi may not always work to identify the binding specificity of VgR with Vg. CRISPR/Cas9, originally originated from an adaptive defense formed by bacteria and archaea, is increasingly used as a cuttingedge tool for gene editing in eukaryotes (Cong et al., 2013; Knott and Doudna, 2018).”
BackgroundThe Role of Long Non-coding RNAs in Human Imprinting Disorders: Prospective Therapeutic Targets
Wang, T., Li, J. J., Yang, L., Wu, M., & Ma, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.730014 · Cited by 38
Dukare, A. S., Mhatre, P. H., Maheshwari, H. S., Bagul, S. Y., Manjunatha, B. S., Khade, Y. P., & Kamble, U. (2022) · 3 Biotech · doi:10.1007/s13205-022-03115-4 · Cited by 35
“Genome modification technologies like CRISPR/Cas9 have rapidly progressed and made it possible to acquire precise genetic information and decipher the molecular facet of PRM interactions (Knott and Doudna 2018).”
BackgroundCheng, X., Xia, X., Ren, D., Chen, Q., Xu, G., Wei, F., Yang, J., Wang, L., Hu, Q., Zou, J., et al. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340748 · Cited by 35
Techniques for investigating lncRNA transcript functions in neurodevelopment
Srinivas, T., Soares, E. S., & Guil, S. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02377-5 · Cited by 38
“2) [37, 38].”
Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment
Li, M., Chen, F., Yang, Q., Tang, Q., Xiao, Z., Tong, X., Zhang, Y., Lei, L., & Li, S. (2024) · Biomaterials Research · doi:10.34133/bmr.0023 · Cited by 36
“As a result, many technologies have been developed for the treatment of tumors at the genetic level [5,6].”
The CRISPR-Cas13a Gemini System for noncontiguous target RNA activation
Zhao, H., Sheng, Y., Zhang, T., Zhou, S., Zhu, Y., Qian, F., Liu, M., Xu, W., Zhang, D., & Hu, J. (2024) · Nature Communications · doi:10.1038/s41467-024-47281-w · Cited by 37
A Smart DNA Nanoframework Enables Synergistic Photodynamic Therapy of Pancreatic Cancer
Song, N., Li, H., Tao, R., Huang, Y. H., Zhang, R., Guo, J.-F., Liu, P., Yao, C., & Yang, D. (2025) · Advanced Materials · doi:10.1002/adma.202416161 · Cited by 32
Kim, J., Koo, B., & Yoon, K. (2019) · Viruses · doi:10.3390/v11020124 · Cited by 35
Bresnick, E. H., & Johnson, K. D. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000378 · Cited by 34
Ding, R., Long, J., Yuan, M., Jin, Y., Yang, H., Chen, M., Chen, S., & Duan, G. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.639108 · Cited by 35
Wörle, E., Jakob, L., Schmidbauer, A., Zinner, G., & Grohmann, D. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab286 · Cited by 33
Deng, F., Li, Y., Qiao, L., & Goldys, E. M. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339351 · Cited by 33
High-throughput methods for genome editing: the more the better
Huang, Y., Shang, M., Liu, T., & Wang, K. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac017 · Cited by 35
Yu, S., Cao, S., He, S., & Zhang, K. (2023) · Small Methods · doi:10.1002/smtd.202201624 · Cited by 32
A Small Molecule-Controlled Cas9 Repressible System
Wu, Y., Yang, L., Chang, T., KANDEEL, F. R., & Yee, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.026 · Cited by 33
“The system has now been developed into a powerful molecular tool for genome engineering, and it has revolutionized the field of biomedical research.(4,5) The most well-known type II CRISPR-Cas9 system consists of Cas9 from Streptococcus pyogenes (SpCas9) and a single guide RNA (sgRNA) with 20 nt complementary to the g…”
Engineering improved Cas13 effectors for targeted post-transcriptional regulation of gene expressionPreprint
Charles, E. J., Kim, S., Knott, G. J., Smock, D. C. J., Doudna, J. A., & Savage, D. F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.26.445687 · Cited by 33
Self-citationGenome editing in plants using the TnpB transposase system
Li, Q., Wang, Y., Hou, Z., Zong, H., Wang, X., Zhang, Y. E., Wang, H., Chen, H., Wang, W., & Duan, K. (2024) · aBIOTECH · doi:10.1007/s42994-024-00172-6 · Cited by 33
“In the past decade, gene editing technologies have enabled precise modifications of specific target genes (Knott and Doudna 2018; Wang et al. 2023).”
BackgroundHLTF disrupts Cas9-DNA post-cleavage complexes to allow DNA break processing
Reginato, G., Stritto, M. R. D., Wang, Y., Hao, J., Pavani, R., Schmitz, M., Halder, S., Morin, V., Cannavò, E., Ceppi, I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50080-y · Cited by 36
“We propose that the larger bands observed with Eco RV and, to a lesser degree, with Cas9, are due to the Cas9/EcoRV ‐ generated ends (phosphorylated) ligating to non ‐ phosphorylated ends via a single phosphate group.”
InfluentialOptions for Engineering Apomixis in Plants
Yin, P. P., Tang, L. P., Zhang, X. S., & Su, Y. H. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.864987 · Cited by 31
Guo, X. W., Tian, T., Deng, X.-C., Song, Y., Zhou, X., & Song, E. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339853 · Cited by 31
CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point‐of‐Care Diagnosis
Dai, Y., Wu, Y., Liu, G., & Gooding, J. J. (2020) · Angewandte Chemie · doi:10.1002/ange.202005398 · Cited by 33
Decoding the microbiome: advances in genetic manipulation for gut bacteria
Chen, Z., Jin, W., Hoover, A., Chao, Y., & Ma, Y. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.05.007 · Cited by 32
Wang, Y., Gao, R., Wu, J., Xiong, Y., Wei, J., Zhang, S., Yang, B., Chen, J., & Yang, L. C. (2019) · Genome biology · doi:10.1186/s13059-019-1839-4 · Cited by 33
“…APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like)/AID (activation-induced deaminase) cytidine deaminase family members [7, 8] with distinct CRISPR/Cas proteins [9, 10], have been developed to achieve programmable C-to-T changes in different sequence contexts or backgrounds.”
BackgroundBaşar, R., Daher, M., Uprety, N., Gokdemir, E., Alsuliman, A., Ensley, E. L., Ozcan, G., Mendt, M. C., Sanabria, M. H., Kerbauy, L. N., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001977 · Cited by 34
A high-fidelity DNAzyme-assisted CRISPR/Cas13a system with single-nucleotide resolved specificity
Wu, Y., Jin, R., Chang, Y., & Liu, M. (2024) · Chemical Science · doi:10.1039/d4sc01501k · Cited by 30
CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model
Kadowaki, A., Wheeler, M. A., Li, Z., Andersen, B. M., Lee, H., Illouz, T., Lee, J.-H., Ndayisaba, A., Zandee, S., Basu, H., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01875-9 · Cited by 33
“Forward genetic screening platforms based on the CRISPR (clustered regularly interspaced short palindromic repeat)–Cas9 (CRISPR-associated protein 9) system are powerful tools to identify regulatory mechanisms associated with biological processes of interest 22–24 .”
Ige, M. A., Ren, X., Yang, Y., Zhang, H., Shen, C., Jiang, Y., Li, J., & Wan, X. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102721 · Cited by 34
“191”
Xu, Z., Li, Y., Cao, H., Si, M., Zhang, G., Woo, P. C. Y., & Yan, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab521 · Cited by 30
“Genome editing and therapeutic applications have focused on the Class 2 CRISPR– Cas systems owing to their simple requirement of a single, multifunctional effector, for example Cas9 and Cas12a, for DNA interference (3,4).”
Organ transplants of the future: planning for innovations including xenotransplantation
Cozzi, E., Schneeberger, S., Bellini, M. I., Berglund, E., Böhmig, G. A., Fowler, K. J., Hoogduijn, M. J., Jochmans, I., Marckmann, G., Marson, L., et al. (2021) · Transplant International · doi:10.1111/tri.14031 · Cited by 31
Wu, L., Zhou, T., & Huang, R. Q. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.131411 · Cited by 30
Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms
Tian, S., Liu, Y., Appleton, E., Wang, H., Church, G. M., & Dong, M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110476 · Cited by 31
“CRISPR-Cas9 and its derivatives have been extensively developed for therapeutic applications (Doudna, 2020; Fellmann et al., 2017; Jinek et al., 2012; Knott and Doudna, 2018; Ran et al., 2015; Shalem et al., 2014; Zhou et al., 2014).”
Protocellular CRISPR/Cas‐Based Diffusive Communication Using Transcriptional RNA Signaling
Yang, S., Joesaar, A., Bögels, B. W. A., Mann, S., & de Greef, T. F. A. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202202436 · Cited by 35
Compact Cje3Cas9 for Efficient In Vivo Genome Editing and Adenine Base Editing
Chen, S., Liu, Z., Xie, W., Yu, H., Lai, L., & Li, Z. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0143 · Cited by 31
Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system
Zhang, B., Lin, J., Perčulija, V., Li, Y., Lu, Q., Chen, J., & Ouyang, S. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac987 · Cited by 30
Hu, M., Liu, R., Qiu, Z., Cao, F., Tian, T., Lu, Y., Jiang, Y., & Zhou, X. (2023) · Angewandte Chemie · doi:10.1002/ange.202300663 · Cited by 31
When genome editing goes off-target
Kempton, H. R., & Qi, L. S. (2019) · Science · doi:10.1126/science.aax1827 · Cited by 31
Xia, Y., Li, Y., Shen, W., Yang, H., & Chen, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015310 · Cited by 31
“CRISPR array transcription produces CRISPR RNA (crRNA), which binds to Cas nuclease and acts on target nucleic acid through specific base complementary pairing [4].”
BackgroundMethodShi, J., Lei, C., Fan, W., Sun, Y., & Liu, C. (2024) · Talanta · doi:10.1016/j.talanta.2024.125906 · Cited by 29
Yan, N., Sun, Y., Fang, Y., Deng, J., Mu, L., Xu, K., Mymryk, J. S., & Zhang, Z. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.021 · Cited by 31
“However, repair by the NHEJ pathway often predominates, restricting the efficiency of the more desirable HDR repair,(4,8) and this negatively impacts the efficiency of precision genome engineering.(9)”
BackgroundLuo, M., Meng, F.-Z., Tan, Q., Yin, W., & Luo, C. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.740177 · Cited by 29
“The Cas12abased DETECTR and HOLMES target dsDNA and detect the signal with fluorescence detection equipment, thus limiting the application under field conditions (Li et al., 2018).”
MethodA Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Chen, X., Guo, R., Zhao, C., Xu, J., Song, H., Yu, H., Pilarsky, C. P., Nainu, F., Li, J., Zhou, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.939090 · Cited by 34
“The gene therapy contains zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the CRISPR/Cas9 system, which knockout, insert, and mutate the targeted gene to treat cancer (Knott and Doudna, 2018).”
BackgroundBis-enzyme cascade CRISPR-Cas12a platform for miRNA detection
Guo, Z., Tan, X., Yuan, H., Zhang, L., Wu, J., Yang, Z., Qu, K., & Wan, Y. (2022) · Talanta · doi:10.1016/j.talanta.2022.123837 · Cited by 29
Tang, D., Yang, Y., Li, Y., Li, Y., Tian, J., Yang, L., Ding, H., Bashir, G., Zhou, H., Ding, Q., et al. (2023) · Theranostics · doi:10.7150/thno.88550 · Cited by 32
“The clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9) system has recently been developed for therapeutic genome editing and has gained widespread attention owing to its incredible genome editing performance [9, 10].”
BackgroundCRISPR propels a smart hydrogel
Han, D., Li, J., & Tan, W. (2019) · Science · doi:10.1126/science.aay4198 · Cited by 29
Ding, T., Lee, K. C. M., Tsia, K. K., Siegel, T. N., Carlo, D. D., & Goda, K. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00334-1 · Cited by 30
Oligonucleotide-Based Therapies for Renal Diseases
Cartón‐García, F., Saande, C. J., Meraviglia-Crivelli, D., Aldabe, R., & Pastor, F. (2021) · Biomedicines · doi:10.3390/biomedicines9030303 · Cited by 29
“Catalytically inactive Cas9 and Cas13 variants have also been fused to other types of functional domains, such as base-pair editors or deaminases able to catalyze A-T to G-C transitions, allowing for single-base edition at the DNA and RNA level without the need to generate double or single-strand breaks [74], or repor…”
BackgroundVersatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9
Liu, Z., Chen, S., Xie, W., Song, Y., Li, J., Lai, L., & Li, Z. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.013 · Cited by 29
Genetic enhancement, human extinction, and the best interests of posthumanity
Rueda, J. (2022) · Bioethics · doi:10.1111/bioe.13085 · Cited by 24
Thapar, N., Eid, M. A. F., Raj, N., Kantas, T., Billing, H. S., & Sadhu, D. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001500 · Cited by 31
“This process of editing genes has been achieved successfully by an inexpensive and precise system known as the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-asso-ciated protein 9 (Cas9) nucleases system [10 – 12] .”
MethodCRISPR/Cas as a Genome-Editing Technique in Fruit Tree Breeding
Martín-Valmaseda, M., Devin, S. R., Ortuño-Hernández, G., Pérez‐Caselles, C., Mahdavi, S. M. E., Bujdoso, G., Salazar, J. A., Martínez-Gómez, P., & Alburquerque, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316656 · Cited by 33
“Both are capable of cleaving dsDNA with just one Cas protein (Cas9/Cas12) being necessary for the recognition and cleavage of the DNA [22]; however, there are some differences in their mechanisms.”
BackgroundCRISPR/Cas detection with nanodevices: moving deeper into liquid biopsy
Kong, H., Yi, K., Mintz, R. L., Wang, B., Xu, Y., Lao, Y., Tao, Y., & Li, M. (2024) · Chemical Communications · doi:10.1039/d3cc05375j · Cited by 28
(2021) · Advances in agronomy · doi:10.1016/bs.agron.2021.02.002 · Cited by 28
Li, Y., Hu, Q., Bai, M., Qing, M., & Bai, L. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06107 · Cited by 32
Programmable genome engineering and gene modifications for plant biodesign
Liu, J., Zhang, R., Chai, N., Su, L., Zheng, Z., Liu, T., Guo, Z., Ma, Y., Xie, Y., Xie, X., et al. (2025) · Plant Communications · doi:10.1016/j.xplc.2025.101427 · Cited by 31
“Unlike protein-based systems such as ZFNs and TALENs, the RNA-guided programmability of Cas9 enables rapid retargeting by modifying the sgRNA sequence (Knott and Doudna, 2018).”
Megabase-scale loss of heterozygosity provoked by CRISPR-Cas9 DNA double-strand breaks
Regan, S. B., Medhi, D., Xu, Y., White, T., Jiang, Y.-Z., Kim, J. E., Wang, S.-C., Deng, Q., Su, J., Baasan, D., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.10.015 · Cited by 29
CRISPR/Cas9-Edited Rice: A New Frontier for Sustainable Agriculture
Mehta, S., Lal, S. K., Sahu, K. P., Venkatapuram, A. K., Kumar, M., Sheri, V., Panditi, V., Vishwakarma, C., Yadav, R., Jameel, M. R., et al. (2020) · Springer eBooks · doi:10.1007/978-981-15-1322-0_23 · Cited by 30
Synthetic directed evolution in plants: unlocking trait engineering and improvement
Rao, G. S., Jiang, W., & Mahfouz, M. M. (2021) · Synthetic Biology · doi:10.1093/synbio/ysab025 · Cited by 30
“Other possible approaches may include the HDR-based retron technology, which brings the repair templates closer to the DSB site.”
BackgroundInfluentialGenomic Editing: The Evolution in Regulatory Management Accompanying Scientific Progress
Goberna, M. F., Whelan, A. I., Godoy, P., & Lewi, D. M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.835378 · Cited by 30
“The difference between NBTs and GMOs is that these innovative tools allow targeted and precise DNA modifications (Barrangou and Doudna, 2016; Knott and Doudna, 2018; Chen et al., 2019).”
BackgroundXie, S., Qin, C., Zhao, F., Shang, Z., Wang, P., Sohail, M., Zhang, X., & Li, B. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00857b · Cited by 27
CRISPR/Cas9 Editing of the Plasmodium falciparum Genome
Adjalley, S. H., & Lee, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_17 · Cited by 27
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing
Rostami, N., Gomari, M. M., Choupani, E., Abkhiz, S., Fadaie, M., Eslami, S. S., Mahmoudi, Z., Zhang, Y., Puri, M., Monfared, F. N., et al. (2024) · Small Science · doi:10.1002/smsc.202400192 · Cited by 31
MDiGest: A Python package for describing allostery from molecular dynamics simulations
Maschietto, F., Allen, B., Kyro, G. W., & Batista, V. S. (2023) · The Journal of Chemical Physics · doi:10.1063/5.0140453 · Cited by 29
Genome-scale targeted mutagenesis in Brassica napus using a pooled CRISPR libraryPreprint
He, J., Zhang, K., Yan, S., Tang, M., Zhou, W., Yin, Y., Chen, K., Zhang, C., & Li, M. (2023) · Genome Research · doi:10.1101/gr.277650.123 · Cited by 29
“…regularly interspaced short palindromic repeat-associated nuclease 9 (CRISPR-Cas9), which mediates target-ededitingwiththecomplexof asgRNAandaCas9 proteinbyrecog-nizing the 20-bp target sites (Jinek et al. 2012), has emerged as a versatile tool for genome engineering (Knott and Doudna 2018).”
A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma
Amjad, E., Pezzani, R., & Sokouti, B. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.044473 · Cited by 29
“Taking into account its ever-expanding repertoire of applications, the CRISPR/Cas9 toolkit excels in gene editing and genetic engineering [63].”
BackgroundXie, R., Wang, Y., & Gong, S. (2021) · Biomaterials Science · doi:10.1039/d1bm00558h · Cited by 28
Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
Zhong, L., Huang, Y., He, J. G., Yang, N., Xu, B., Ma, Y., Liu, J., Tang, C., Luo, C., Wu, P., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00799-7 · Cited by 26
“recruited to the target site to cut the DNA, allowing removal (deletion) and addition (insertion) of DNA fragments.(14,15) Indeed, the CRISPR/Cas9 system is a revolutionary, yet feasible genomeediting tool.”
BackgroundYou can't keep a bad idea down: Dark history, death, and potential rebirth of eugenics
Liscum, M., & Garcia, M. L. (2021) · The Anatomical Record · doi:10.1002/ar.24849 · Cited by 33
Zhao, J., Kennedy, S. D., & Turner, D. H. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00643 · Cited by 28
Activation of stably silenced genes by recruitment of a synthetic de-methylating module
Chan, W. F., Coughlan, H. D., Chen, Y., Keenan, C. R., Smyth, G. K., Perkins, A. C., Johanson, T. M., & Allan, R. S. (2022) · Nature Communications · doi:10.1038/s41467-022-33181-4 · Cited by 28
CRISPR/Cas9 in the era of nanomedicine and synthetic biology
Schmidt, T. J. N., Berarducci, B., Konstantinidou, S., & Raffa, V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103375 · Cited by 29
Choudhary, N., Tandi, D., Verma, R. K., Yadav, V. K., Dhingra, N., Ghosh, T., Choudhary, M., Gaur, R. K., Abdellattif, M. H., Gacem, A., et al. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1164461 · Cited by 27
“There are currently more than a thousand phages that attack a bacterium each and every day (Knott and Doudna, 2018).”
BackgroundDeep Tumor Penetration of CRISPR-Cas System for Photothermal-Sensitized Immunotherapy via Probiotics
Luo, W., Zhang, Z., Zhou, D., Jiang, Y., Yang, J., He, B., Yu, H., & Song, Y. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c02061 · Cited by 27
The Role of Orthogonality in Genetic Code Expansion
Arranz‐Gibert, P., Patel, J. R., & Isaacs, F. J. (2019) · Life · doi:10.3390/life9030058 · Cited by 31
Parveen, S., Akhtar, N., Ghauri, M. A., & Akhtar, K. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1772195 · Cited by 26
“It is a revolutionary and flexible tool that is extensively used for precise and targeted genome editing of eukaryotes as well as prokaryotes (Adli 2018; Knott and Doudna 2018; Langner et al. 2018; Mougiakos et al. 2018; Tong et al. 2018).”
MethodSuñé-Pou, M., Limeres, M. J., Moreno‐Castro, C., Hernández-Munaín, C., Suñé-Negre, J. M., Cuestas, M. L., & Suñé, C. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00731 · Cited by 28
“In recent years, genome editing techniques involving zinc finger (ZF) proteins (ZFPs), transcription activator-like nucleases (TALENs) and CRISPR/Cas9 systems have become new treatment avenues for correction of splicing defects (Hsu et al., 2014; Fernandez et al., 2017; Knott and Doudna, 2018).”
BackgroundYang, X., Bui, T. A., Mei, H., Aksoy, Y. A., Deng, F., Hutvágner, G., & Deng, W. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402630 · Cited by 33
Cuproptosis and its potential role in musculoskeletal disease
Xiang, Z., Mei, H., Wang, H., Yao, X., Rao, J., Zhang, W., Xu, A., & Lü, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1570131 · Cited by 30
“Epigenetic regulation includes DNA methylation, histone modification (Knott and Doudna, 2018).”
O’Brien, A. R., Burgio, G., & Bauer, D. C. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz145 · Cited by 28
“The CRISPR system can also be used for other applications, such as nucleic acid detection [4] or CRISPR-based diagnostics [5], with additional uses reviewed in [6].”
MethodThe CRISPR revolution and its potential impact on global health security
Watters, K. E., Kirkpatrick, J., Palmer, M. J., & Koblentz, G. D. (2021) · Pathogens and Global Health · doi:10.1080/20477724.2021.1880202 · Cited by 35
“particular has become widely used for specific targeting and cleavage of DNA or RNA, with many potential applications in biomedicine including studying the host–pathogen relationship, editing the host genome for pathogen resistance, detecting pathogens, and directly targeting pathogens for therapeutic purposes [3].”
BackgroundGene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations
Wang, Y., Hu, L., Zhou, T., Qi, L., Xing, L., Lee, J., Wang, F., Oh, Y., & Jiang, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121108 · Cited by 25
Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19
Kwon, S., & Shin, H. Y. (2021) · Life · doi:10.3390/life11121356 · Cited by 29
“and CRISPR-associated proteins (Cas) were originally detected as components of the adaptive immune systems in bacteria and archaea, defending these organisms against invading viruses by degrading foreign genetic elements [11,12].”
BackgroundRehman, F., Gong, H., Bao, Y., Zeng, S., Huang, H., & Ying, W. (2022) · Plant Molecular Biology · doi:10.1007/s11103-021-01229-6 · Cited by 27
“The naturally occurring programmability of this diverse system enables the CRISPR-Cas gene editing ability beyond precision (Knott and Doudna 2018).”
BackgroundGodbole, N., Quinn, A., Carrión, F., Pelosi, E., & Salomón, C. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.002 · Cited by 27
Yang, R., Xie, S., Zhou, B., Guo, M., Fan, J., Su, F., Ji, Z., Chen, Y., & Li, B. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c18732 · Cited by 25
Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications
Tang, N., & Ji, Q. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00247 · Cited by 25
Wandera, K. G., Collins, S. P., Wimmer, F., Marshall, R., Noireaux, V., & Beisel, C. L. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.014 · Cited by 28
Maroc, L., & Fairhead, C. (2019) · Yeast · doi:10.1002/yea.3440 · Cited by 25
“…to be set up in some cases. wileyonlinelibrary.com/journal/y One of the most promising genome engineering technologies is the CRISPR‐Cas9 system (Knott & Doudna, 2018; Roy et al., 2018), and this bacterial system, relying on the Cas9 endonuclease and a guide RNA (gRNA), has been adapted to…”
Background
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.